Blog
These blog posts explore GP2’s work in further understanding the genetic architecture of Parkinson’s disease.
The Components of GP2’s Second Data Release
By GP2 Complex Disease Data Analysis Working Group and Monogenic Data Analysis Working Group | Complex Disease Genetics, Research Collaboration, Research Operations |Learn MoreIn April 2022, GP2 announced the second data release on the Terra platform in collaboration with AMP® PD. This release contains data from both complex and mono…
Surgicogenomics and Individuals with GBA Mutations
By Benjamin Stecher and Alfonso Fasano | Complex Disease Genetics |Learn MoreBenjamin Stecher and Alfonso Fasano discuss how using genetic information as a prognostic indicator might be relevant to assess surgical outcomes.
The Components of GP2’s First Data Release
By GP2 Complex Disease Data Analysis Working Group | Complex Disease Genetics, Research Collaboration, Research Operations |Learn MoreLearn more about the process to gather genotype and clinical data as well as the different tiers of data access available.
Building Clinical and Genetic Data for GP2 in the Cohort Integration Working Group
By Huw Morris | Complex Disease Genetics |Learn MoreHuw Morris leads the Cohort Integration working group (CIWG). In this blog post, Huw provides an outline of the research on Parkinson’s disease over the last 2…
Understanding GWAS: Part 2 – Additional Insights and Tips
By GP2 Complex Disease Data Analysis Working Group | Complex Disease Genetics |Learn MoreAs a follow-up to the last blog post on Understanding GWAS, the GP2 Complex Disease Data Analysis Working Group has provided practical tips and insights for ru…
Understanding GWAS
By GP2 Complex Disease Data Analysis Working Group | Complex Disease Genetics |Learn MoreMembers of the GP2 Complex Disease Data Analysis working group provide an overview of Genome-Wide Association Studies (GWAS), including statistical formulae, w…